Mouse-adapted influenza B virus for in vitro and in vivo assessment of therapeutic and preventive efficacy of antiviral drugs-Reference-Cited by-同舟云学术

Mouse-adapted influenza B virus for in vitro and in vivo assessment of therapeutic and preventive efficacy of antiviral drugs

Published:2019-12-08 Issue:4 Volume:11 Page:53-64
ISSN:2499-9865
Container-title:Journal Infectology
language:
Short-container-title:test

Author:

Prokopyeva E. A.¹,Kurskaya O. G.²,Solomatina M. V.²,Sobolev I. A.²,Murashkina Т. A.²,Derko А. A.²,Korchagina K. V.³,Yunusova A. Yu.³,Alekseev A. Yu.⁴,Shestopalov A. М.²,Sysolyatin S. V.⁵,Vorozhtsov A. В.⁶,Vaizova О. Е.⁷,Sherstoboev E. Yu.⁸,Sharshov К. A.²,Dygai А. М.⁸

Affiliation:

1. Federal Research Center of Fundamental and Translational Medicine; Novosibirsk State University

2. Federal Research Center of Fundamental and Translational Medicine

3. Institute of Chemical Biology and Fundamental Medicine

4. Federal Research Center of Fundamental and Translational Medicine; Dagestan State University, Makhachkala

5. Institute for Problems of Chemical and Energetic Technologies

6. National Research Tomsk State University

7. Siberian State Medical University

8. Research Institute of Pharmacology and Regenerative Medicine named after E.D. Goldberg of Tomsk National Research Medical Center

Publisher

SPRIDA

Subject

Infectious Diseases

Reference31 articles.

1. Bodewes, R. Recurring influenza B virus infections in seals / R. Bodewes, D. Morick, G. de Mutsert et al. // Emerging infectious diseases. — 2013. — № 19(3). — P. 511-2

2. Osterhaus AD, Rimmelzwaan GF, Martina BE, et al. Influenza B virus in seals. Science, 2000;288(5468):1051-1053.

3. Su S, Chaves SS, Perez A, et al. Comparing clinical characteristics between hospitalized adults with laboratory-confirmed influenza A and B virus infection. Clin. Infect. Dis., 2014;59(2):252-255.

4. Chen M. World at the beginning of the 2009 influenza pandemic. WHO. Who Director-General Dr Margaret Chan's press statement 11 June 2009 ghttps://www.who.int/mediacentre/news/statements/2009/h1n1_pandemic_phase6_20090611/ru/ (01.07.2009)

5. Adlhoch C, Snacken R, Melidou A, et al. The European Influenza Surveillance Network. Dominant influenza A(H3N2) and B/Yamagata virus circulation in EU/EEA, 2016/17 and 2017/18 seasons, respectively. Euro Surveill. 2018;23(13):pii=18-00146. https://doi.org/10.2807/1560-7917.ES.2018.23.13.18-00146